Icon

SILENOR (nda022036)- (EQ 3MG BASE,EQ 6MG BASE)

DOXEPIN HYDROCHLORIDE CURRAX
EQ 3MG BASE,EQ 6MG BASE
Yes Yes
2030-Sep-07 Expired
None 2013-Mar-17
None No
SILENOR (doxepin) tablets are indicated for the treatment of insomnia characterized by difficulties with sleep maintenance.
7 0 6
Total Other Developers 4
Drugs with Suitability No
EQ 3MG BASE ** ** - - 4
EQ 6MG BASE ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** ** ****** ***. *********** *** * ********** ** *** ***/*** *, ***** *****, *** **** (**) *****, ****** ****** (***) ***
****** ** ****** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ** ****** ***** ****** *** *********** *** *** ************ **, **********, *** ****** (**) *****, ****** ****** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ******* ****** ******* ******, *** *********** * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) ***
****** *** *** *************** *** *********** **, **** ****, **********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.